Diet-microbe interactions play an important role in modulating the early life microbiota, with 13
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31
The early life developmental window represents a critical time for microbe-host interactions 32 as this is when foundations for future health and wellbeing are established. Colonisation of 33 pioneer microbes shortly after birth represents a key first step in this mutualistic relationship; 34 shaping the developing microbial community, and in turn impacting numerous host 35 physiological processes (1,2). Although the microbiota of adults is complex in nature, the 36 gastrointestinal (GI) tract of full term healthy infants is relatively simplistic, with upwards of 37 80% of the total microbiota being comprised of the genus Bifidobacterium (1). Loss of 38 Bifidobacterium, or indeed gain of other species during this critical window of opportunity, 39 may significantly alter the entire community with negative consequences for host health (3). 40
In infants, Bifidobacterium can be considered a foundation microbiota member which, 41 due to their abundance, strongly influence the environment, the structure of burgeoning 42 microbial communities and host development (4,5). Infant diet is suggested to be one of the 43 key factors that shapes the early life microbiota, and recently the WHO (6) and the Scientific 44 Advisory Committee on Nutrition (UK) (7) released new guidelines regarding the optimal 45 time to start breast feeding, and highlighted the health benefits associated with solely breast-46 feeding infants. In breast-fed infants, the early life microbial community is dominated by a single bacterial genus Bifidobacterium; that is, until the diet changes to include either infant 48 formula and/or simple solid foods. It is known that breast-fed and formula-fed infants differ 49 in microbial composition (8), including significant differences in bifidobacterial populations, 50 which has also been linked to differential health outcomes, both in the short-and longer-term 51
i.e. induction of allergies, asthma and obesity in formula fed infants (8, 9) . 52 Establishment of this bifidobacterial dominant community in response to diet 53 (specifically breast milk) suggests a cooperative relationship between different strains and 54 species, rather than competition, which is often described for other bacterial species (10). 55
Indeed, it appears that closely related Bifidobacterium strains coexist in a single infant GI 56 tract, rather than one strain dominating and competitively excluding other strains. However, a 57 cooperative balance between bifidobacterial strains in the early life microbiota may further 58 enhance their dominance in breast fed infants by enabling a genus-specific exploitative 59 competition i.e. depleting the GI tract of breast milk-derived nutrients, thereby preventing 60 colonisation of other microbes, including pathobionts. To investigate these key community 61 dynamic questions, we have probed the genomic and phenotypic similarities between 62 bifidobacteria strains that coexist in the same individual, including their responses to specific 63 early life diet components, namely human milk oligosaccharides (HMOs). By examining 64 microbial interactions on a strain-level we provide important insights into how multiple bifidobacterial pan genome are involved in carbohydrate metabolism, thereby reflecting their 100 ability to grow within the glycan rich environment of the colon (12,13). We functionally 101 characterised genomes and determined that, apart from genes of unknown function, genes 102 classified as carbohydrate transport and metabolism were the most abundant in all genomes, 103
indicating the saccharolytic lifestyle of Bifidobacterium spp. ( Fig 1C and Table S3 ). Strains 104 from infant V1 had the highest percentage of carbohydrate metabolism and transport genes of 105 all infants (10.32%), followed by strains from infant V2 (10.06%), and then infant V3 106 (9.53%). Based on functional genome analysis there appears to be interspecies differences in 107 genes associated with carbohydrate transport and metabolism, for example, 10.67± 0.11% of 108 the total genome of B. pseudocatenulatum strains from infant V1 were dedicated to this 109 functional group, whereas V3 B. pseudocatenulatum strains had 1% less (9.60±0.18%) of 110 their genome annotated for carbohydrate use. These data suggest the same species in different 111 ecological niches (i.e. infant) may have altered metabolic function. 112
Due to the high proportion of B. pseudocatenulatum strains isolated from infant 113 V1 and V3, and apparent differences in functional annotation, we further investigated 114 differences in the core and accessory genes ( Fig. S3A , Tables S6A & S6B ). B. 115 pseudocatenulatum strains from the same infant shared a large core genome, but there were 116 minor differences in accessory genes. Strains from infant V1 had more unique genes 117 compared to strains from infant V3 ( Fig S3) . Further characterisation of these unique genes 118 indicated that infant V1 strains LH13 and LH14 possess unique putative carbohydrate 119 utilisation gene clusters (LH_13_00067-LH_13_00071 and LH_14_01835-LH_14_01839) 120 that are not present in other strains and may contribute to altered carbohydrate digestion. The 121 LH14 genome also contains genes encoding fimbriae and sortase genes (LH_14_01074-6 and head proteins and a tyrosine recombinase, however, due to the size of the cluster it is 125 likely to be an unsuccessful phage insertion event. Interestingly, two large partial prophage 126 clusters were also identified in genomes of LH656 and LH658 from infant V3 (Table S7A & strains must first be able to traverse the length of the GI tract, to their preferred niche i.e. the 156 colon. When exposed to acid shock at pH2 for four hours (representing stomach pH and 157 transit time), all strains (except B. breve LH24) were able to re-establish growth in MRS 158 media ( Fig 3A) . As expected all strains exhibited poor growth in aerobic, compared to 159 anaerobic conditions, although there was modest growth in some strains, which might 160 suggest an ability for vertical and horizontal transmission ( Fig 3B) . Growth in 0.3% bovine 161 bile salt resulted in statistically significantly less growth of all strains, except for B. infantis 162 LH23 from infant V2 ( Fig 3C) . All strains contained homologs to known bile salt hydrolase 163 genes (Table S3 ), and therefore we tested the ability of each strain to hydrolyse specific 164 individual bile salts including taurocholic acid, taurodeoxycholic acid and sodium 165 glycodeoxycholate bile acids (Table S4) LH665 and LH666 ( Fig 4A) , however, the genetic organisation of this cluster varied in our 192 infant isolates. Importantly, homologues to all three GH contained within the cluster are 193 found in similar clusters in our genomes, however, instead of a large continuous cluster, LH277 as this cluster has also been described for B. longum JCM1217 . B. infantis strains 217 LH664, LH665 and LH666 contained a partial lnp/glt cluster with highly similar enzymatic 218 genes, but no transporter genes in close genomic proximity, suggesting that these strains may 219 degrade LNB, but may transport this HMO using other genes in the genome. 220
Sialidases aid breakdown of sialidated HMOs and B. bifidum ATCC 15696 has an 221 extracellular sialidase (SiaBb1) that can digest these HMOs without importing them into the 222 cytosol (24,25). Our analysis identified sialidases in B. infantis strains LH23, LH664, LH665 223 and LH666, however, the required transmembrane domains were absent suggesting that these 224 strains are intracellular sialidase utilisers (Table S8 ). Thus, it appears that infant-specific 225 strains may maximise utilisation of a wide assortment of HMOs within a community via 226 differential genetic adaptation to a breast-milk diet and early life niche. 227 228 Phenotypic characterisation of HMO usage indicates known and unknown enzymatic 229 gene clusters. Next to lactose, HMOs are the second most abundant carbohydrate in breast 230 milk (5-15 g/L in breast milk) (26), and are a key metabolic source for Bifidobacterium 231 (27,28). Although we identified a wide range of putative HMO genomic clusters in our 232 strains, we next sought to correlate these with an ability to metabolise HMOs, in particular 233 2'FL and LNnT ( Fig. 4B -D). We were able to identify strains capable of using either 2'FL or 234
LNnT in each microbial ecosystem. All B. pseudocatenulatum strains, but not the B. longum 235 LH12 strain, from infant V1 could degrade the HMO 2'FL, most likely due to the presence of 236 a known fucosylated HMO utilisation gene cluster ( Fig 4A) . Only B. pseudocatenulatum 237 LH11 was capable of using the more complex HMO, LNnT, despite lacking known 238 enzymatic clusters, suggesting an alternative or novel mechanism of degradation. Collectively these data demonstrate that HMO utilisation is dependent on the type of HMO 248 and the strain tested; supported by the fact that type strains for each species also had 249 differential HMO degradation ( Fig. S4 ). 250 251 A syntrophic network for HMO utilisation exists within Bifidobacterium species. It is 252 clear that multiple stains and species exist as a community within a single ecosystem (i.e. 253 infant), and that these bifidobacterial communities encode a diverse array of metabolic genes, 254 which correlates with strain-specific breakdown of breast milk-associated HMOs. Thus, to 255 assess how these bifidobacterial communities interact with each other, we determined if 256 strains unable to degrade HMOs, could utilise the metabolic by-products generated by HMO 257 degraders. To address this experimentally, all strains that had previously been found to use 258 either 2'FL ( Fig 4C) or LNnT ( Fig 4D) were grown in their respective HMOs, and 259 conditioned media was filtered and used as a carbon source for all other non-HMO users 260 within the same infant community ( Fig 5A) . We found that 2'FL derived-substrates from all 261 B. pseudocatenulatum strains in infant V1 supported growth of B. longum LH12 ( Fig 5B) . 262
This demonstrates a syntrophic/cross-feeding network, and cooperation between different 263 species within the same ecological niche. Conversely, V2-associated B. breve strain 264 breakdown products did not support B. infantis LH23 growth, indicating that these strains 265
were not able to cross-fed when HMO 2'FL is the initial carbon source. Both B. longum and 266 two B. infantis isolates from infant V3 (LH206, LH277, LH664 and LH665 respectively) 267 grew on 2'FL, however only the conditioned media from isolate B. longum LH206 could 268 support growth of other isolates within the same infant. Interestingly, bioinformatic analysis 269 did not identify any alpha-fucosylase genes in LH206. Moreover, LH206 conditioned media 270 enhanced growth of all tested isolates (both B. infantis and B. pseudocatenulatum species), 271 which suggests the metabolism of 2'FL by LH206 may generate a wide variety of 272 components for neighbouring isolates to use for growth within this ecosystem (i.e. infant V3).
Overall fewer isolates could grow using the more complex HMO LNnT, and as a 274 result no strains from infant V1 were tested. In contrast to the 2'FL growth profile, B. infantis 275 LH23 strain utilised LNnT, but associated by-products did not support growth of either B. 276 breve isolates from infant V2 ( Fig 5C) 
Metabolite analysis indicates specific metabolic components involved in syntrophic 284
network. We next sought to identify the metabolic compounds involved in these cross-285 feeding networks for both 2'FL and LnNT HMOs. Using 1 H-NMR we analysed the 286 metabolic compounds generated by B. longum LH206 after growth, using 2'FL as a sole 287 carbon source, and compared that to B. pseudocatenulatum LH659 after growth on cell-free 288 supernatant from LH206 ( Fig 6A) . B. longum LH206 produced formate, lactose, galactose, 289 glucose, fucose and acetate in response to growth on 2'FL, and these compounds were 290 reduced after B. pseudocatenulatum LH659 growth, suggesting active metabolism ( Table S9 ). In addition, LH659 when grown on LH206 conditioned media resulted 292 in production of the metabolite intermediate pyruvate. Cross-feeding experiments using 293 strains from infant V1, indicated that HMO degrader B. pseudocatenulatum LH13 and HMO 294 non-degrader B. longum LH12 produced similar results ( Fig S6) . 295 B. longum LH206 can also use LNnT for growth, therefore we also profiled cross-296 feeding metabolites using the non-LNnT degrader, B. pseudocatenulatum LH663 from infant 297 V3 ( Fig 6B, Fig S7 and Table S9 ). Similar to the 2'FL cross-feeding experiments, we 298 observed production and consumption of many metabolites; in particular LH206 generated 299 free galactose from LNnT digestion that was no longer detectable in the conditioned media 300 from LH663, indicating galactose had been consumed for growth. There was also an increase 301 in the energy-related compound formate and the end product of fermentation ethanol, 302
suggesting that LH663 was also producing these metabolites in response to growth. In 303 addition, we also examined the metabolic profile of strain B. longum LH206 cross-feeding to 304
B. pseudocatenulatum LH657 and found additional ethanol production from LH657; but also 305 noted that it consumed acetate, galactose, and N-acetyl glucosamine, by products of LnNT 306 degradation by B. longum LH206 ( Fig S8) . Notably, strain B. longum LH206, and not isolate 307 LH277, could digest all HMOs tested, and generated a variety of metabolic by-products that 308 could be consumed by other bifidobacterial strains. Although strain specific, metabolic by-309 products produced by these HMO degraders, can be used as 'public goods' to be shared 310 amongst the Bifidobacterium community, thus demonstrating cooperative traits that likely 311 contributes to bifidobacterial survival in the early life infant gut (Fig 7) . 312 313 Discussion 314 Bifidobacterium spp. are central players in the early life microbiota and healthy infant 315 development. We show that this genus is present at very high levels in breast fed infants, and 316 that distinct bifidobacterial communities exist within an individual infant ecosystem. Our 317 data indicates a diverse genomic landscape for these individual strains, which links to their 318 ability to thrive on breast milk-associated dietary components i.e. HMOs within a 319 'community' setting. These data highlight the important role that communities of 320 bifidobacteria play in an early life environment, and suggests avenues for development of From three healthy breast-fed infants we isolated a significant number of diverse 323 bifidobacterial strains and species including members commonly associated with the infant 324 microbiota i.e. B. infantis, B. longum, B. breve and B. pseudocatenulatum (29,30). One 325 proposed method that Bifidobacterium are acquired by infants is through vertical 326 transmission from their mother's vaginal canal during birth as vaginally born infants tend to 327 have a higher proportion of Bifidobacterium than those delivered by C-section (31,32). 328
However, horizontal transmission may also occur as the microbiota profile of C-section and 329 vaginally born infants converge after as little as six weeks (33). Both vertical and horizontal 330 transmission of Bifidobacterium to the infant gut require the ability to withstand oxygen 331 exposure and passage through the environmental stressors of GI tract i.e. acid and bile 332 exposure (34). In this study, 18 of 19 strains were showed resistance to all the above 333 environmental stressors and this indicates these strains have adapted to allow for effective 334 transmission to the host. 335
There are distinct genotypic and phenotypic differences between the strains within a 336 single infant bifidobacterial community; however, these differences enable a flexible and 337 cooperative relationship in a breast milk diet (i.e. HMOs) environment that may support 338 dominance of this genus in the wider early life microbiota. HMOs represent a key nutritional 339 component of breast milk, but these complex carbohydrates cannot be directly metabolised 340 by the infant (35). In infants specialised members of the resident gut microbiota allow the 341 breakdown of these compounds, in particular Bifidobacterium utilises HMOs and likely 342 contributes to its function as a foundation genus in early life (17,27). Multiple studies have 343 identified genomic clusters for the degradation of these oligosaccharides, including specific 344 clusters for utilisation of specific HMOs (18, 21, 22) . We determined that the genomic 345 arrangement of these clusters exhibits interspecies variability and, consistent with other 346 studies, the presence of these clusters does not always result in a growth phenotype on specified HMOs. For instance, both B. breve strains in this study possessed a key GH for 348 fucosylated HMO degradation, but did not grow on 2'FL which could potentially be due to 349 the lack of a second fucosidase (GH29) or appropriate transport genes (20). Furthermore, we 350 identified growth on HMOs in strains lacking known clusters, suggesting a wider variety of 351 novel gene clusters devoted to HMO degradation that could be explored further to provide 352 more mechanistic rationale for development of early life microbiota therapies 353
Cross-feeding of HMO metabolites between Bifidobacterium is a proposed 354 mechanism to allow for non-HMO degraders to survive in the HMO rich environment of the 355 breast-fed infant gut (12,25,36). Recently it has been shown that extracellular sialidases on B. 356 longum produce sialylated carbohydrates and free sialic acid to promote B. breve growth 357 (24,25); however, there is little evidence suggesting co-operation between non-extracellular 358 HMO degraders. We have identified that by-products of HMO degradation can be utilised by 359 non-degraders from the same infant suggesting sharing of resources within a single host. For 360 example, by products of 2'FL degradation from B. pseudocatenulatum strains can support the 361 growth of B. longum (Fig 7) . Cross-feeding has not been described for B. pseudocatenulatum 362 to B. longum previously, however, 2'FL has been shown to allow cross-feeding between the 363 intracellular 2'FL degrader B. infantis and another microbiota member, Eubacterium halli, 364 driven by the 2'FL metabolic end product of 1,2, propanediol (37). Whilst we did not identify 365 this specific product in our system, we did see the consumption of other end products of 366 carbohydrate metabolism including fucose, acetate and pyruvate, which may be sustaining 367 growth in these cross-feeding events. This suggests a more generic sharing of resources 368 between Bifidobacterium strains that may also encourage growth of the wider infant gut 369 microbiota including minor, but important members such as Escherichia coli (38) and
The impact of community sharing of metabolites suggests cooperation between 373
Bifidobacterium strains in the infant gut and eludes to the lack of resource competition that 374 has previously been described for identical species within a single ecosystem. It is plausible 375 that due to the abundance of Bifidobacterium in early life these cross-feeding events occur 376 specifically within the Bifidobacterium community. This advantage is likely key for 377 bifidobacteria survival and ultimate exclusion of potential invading bacteria into the early life 378 microbiota, and suggests Bifidobacterium are foundation species that may act as ecosystem 379 engineers, constructing and shaping the gut microbiota in early life. Our results demonstrate 380 that HMO utilisation is strain-specific, and Bifidobacterium ultimately have different and 381 complementary carbohydrate degradation mechanisms. Since we examined strains from 382 within a single ecological niche, it is likely that there is shared used of available resources 383 from the infant diet through metabolic cooperation and enables engraftment of 384
Bifidobacterium in the infant microbiota. Similar to our findings, recent work has also 385 proposed cooperation amongst multiple Bifidobacterium isolates from an SHIME model 386 colon system based on their ability to utilise and share the metabolic components of inulin-387 type fructans and arabinoxylan oligosaccharides present in the adult diet (40). Despite the 388 concept that similar strains of a specific species tend to compete against each other for shared 389 resources and stable engraftment of new bacteria is enhanced in the absence of other 390 members of the same species (41), our data provides support that positive interactions, like 391 cooperation phenotypes, predominate in single microbial communities and environments 392 (42). In this work, for the first time we have identified altruistic behaviour in B. longum strain 393 LH206 to produce a variety of metabolites from HMO degradation that directly promotes the 394 growth of other Bifidobacterium strains within the same environment, clearly demonstrating 395 a form of social cooperation between microbes at an individual level. However, what remains 396 to be determined is whether or not there is also mutualistic cooperation occurring, i.e. that LH206 receives a benefit from other strains within the community. Collectively, this research 398 provides new insight into the social behaviour of these proposed foundation species and how 399 they function collectively as a group to maximise nutrient utilisation from breast milk to 400 dominate the infant gut. Determining these interactions with respect to infant diet, will be 401 critical for development of optimal multiple strain/species microbiota therapies to promote 402 early life health. were analysed using 1 H-NMR Spectroscopy. Media samples were mixed (2:1) with 0.2M 478 sodium phosphate buffer solution (pH 7.4) made in 100% deuterium oxide and 0.01% of sodium 3-(trimethylsilyl) [2,2,3,3,-2H4] propionate 3mM NaN 3 . The mixture was vortexed 480 and centrifuged and transferred to a 5mm outer diameter NMR tube (Wilmad). One-481 dimensional spectroscopic data were acquired using a 500 MHz NMR spectrometer (Bruker 482 Biospin, Germany) operating at 300 K. A standard one-dimensional NMR pulse sequence 483 with water pre-saturation was applied to acquire spectroscopic data, using 4 dummy scans 484 followed by 64 scans and collected into 24 K data points. 1 H NMR spectra were manually 485 corrected for phase and baseline distortions and referenced to the TSP signal at 
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